Navigation Links
Growing Popularity of Cholesterol-lowering Drugs Raises Concern

A novel analysis about the usage of cholesterol lowering drugs has revealed the trend of healthy people using this drug as a means to prevent heart disease; Researchers warn// that these drugs are to be employed only to lower life-threatening health risks for those suffering vascular disease.

Popularly called statins, these drugs are beneficial in reducing the risk of heart attack and cardiovascular problems in patients suffering artery disease. The analysis revealed the most disconcerting aspect, that 75% of its users did not portray substantial evidence of vascular disease, to warrant a cholesterol lowering drug.

‘It's not a trivial, minor thing. It's the bulk of the prescribing,’ says Dr. Jim Wright, a professor at the University of B.C.

Wright and co-author Dr. John Abramson of Harvard Medical School, collated data from eight randomized trials that endeavored to compare statins with a placebo - in people who suffered a high risk of cardiovascular disease. The study revealed that statins did not make an impact in reducing the number of deaths. Further there was no palpable benefit to women.

In totality, researchers said that statins did bring down the risk of heart attack or stroke. But the complete risk cover was only about 1.5%, which is very little, researchers opined. Upon closer observation, the gains appeared to reflect only in the high risk category.

‘Most people have the impression that statins are going to make them live longer. For primary prevention, there hasn't been demonstrated to be any survival advantage,’ Wright said.
SV
'"/>




Page: 1

Related medicine news :

1. Problems Of a Growing Company
2. Growing trend of delay in completing vaccination schedule
3. Growing tissues
4. Women Growing Up In Poverty At Increased Risk Of Heart Disease
5. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
6. Extensive Campaigning To Warn Against Children’s Growing Affinity To Fast Food In Britai
7. Another Potential Of Stem Cells Discovered: Used For Growing Cartilage
8. Americans Growing Out Of Shape
9. Kids Face a Slim Chance of Growing Obese, If Breastfed Longer Than Three Months
10. Breast Cancer Survivors Growing in Numbers
11. Growing Drug Addiction Rate among Elderly Population

Post Your Comments:
(Date:11/24/2009)...ANCLEMENTE,Calif.,Nov.24/PRNewswire/--Bionorica,an...turalremedies,announcedtodaytheavailabilityofnewed...sforchildren,shealth.Atipsheeton"StayingNaturallyH...alMoms"series,isnowavailableonthecompany,swebsitea...hewebsiteforafreesubscriptiontotheNaturalMomstipsh...
(Date:11/24/2009)...IRMINGHAM,Ala.,Nov.24/PRNewswire-FirstCall/--Healt...articipateintheBankofAmericaMerrillLynch2009Credit...thSeniorVicePresidentandTreasurerEdFaywillbespeaki...onwillbewebcastliveandwillbeavailableat http://inv... ,, AboutHealthSouth ,, HealthSouthisthena...
(Date:11/24/2009)...erbal supplement may help ward off peripheral arte..., Nov. 24 (HealthDay News) -- Among people aged 75...es not prevent heart attacks, stroke or death, a n...he popular herbal remedy might help prevent the le...isease, however. , Ginkgo contains nutrients ca...
(Date:11/24/2009)...ds that quitting improves heart prospects, but can...ealthDay News) -- A new study offers yet more proo...om heart disease and cancer. , Researchers foll...smokers, formers smokers and nonsmokers for three ... times more likely to die of cancer, 2.26 times mo...
(Date:11/24/2009)...t contributes to the falls that plague older adult...ealthDay News) -- Falls are a leading cause of dea...s that chronic pain contributes to those accidents... muscle weakness, and is associated with mobility ...udy authors wrote. , "Chronic pain, no matter h...
Breaking Medicine News(10 mins):Health News:Bionorica Offers Expert Resources, Health Tips for 'Natural Moms' 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Smokers Double Their Risk for Heart Disease 2Health News:Chronic Pain Trips Up Seniors 2Health News:Chronic Pain Trips Up Seniors 3
...s advantage Indian pharma companies and the needy ...urchase life-saving drugs, with global pharma gian...drugs commanding multi-billion annual sales. ...ated by the patent expiry of two biggest blockbust...
...aria has so far claimed at least 47 lives in Aruna...al alone accounting for 27 deaths, official source...ecorded 10 deaths, R K Mission hospital sources re...ay, official sources had said that malaira had cla...
...estigating on the target areas, where ADHD drugs a...argets the prefrontal cortex (PFC) region of the b...regions. Researchers at the University of Wisc...t new work at the University of Wisconsin-Madison ...
...ording to a new study, men with prostate cancer ar...motional changes, which prevents them //from trus...owed misconceptions on the disease management opti...re entirely different from them are the reasons fo...
...is found that people suffering from Rheumatoid art... results of the study were presented at the Europe...atoid arthritis occurs in elderly people. It is ch...mplete immobility. According to the study it w...
...rogram that was begun some six years ago has final... teens are attended by mobile doctors //thereby ge... The program had initiated the use of a 33-foot-... they need as early as possible in their pregnanci...
Other Medicine News:Health News:Effect of ADHD Drugs on the Brain - Study Finds 2Health News:Effect of ADHD Drugs on the Brain - Study Finds 3Health News:Misconception on Treatment Options among Prostate Cancer Patients 2
(Date:11/24/2009).../--PharmaceuticalInstitute,aleadingproviderofspeci...echindustry,todayannouncedthelaunchofanewe-courset...lace e-courseisthenewestadditiontothecompany,s Man...iesofe-coursesdesignedtofillthecriticalneedforbasi...ofessionals. ,, Thenewthreemodule HospitalMarke...
(Date:11/24/2009)...SNewswire/--America,spharmaceuticalresearchandbiot...totreatorpreventHIV/AIDSandrelatedconditions,accor...searchandManufacturersofAmerica(PhRMA).December1ma...nesscampaignthatoriginatedatthe1988WorldSummitofMi..., "Wearegreatlyencouragedbythesecriticallyimportan...
(Date:11/24/2009)...-FirstCall/--LotusPharmaceuticals,Inc.,(OTCBulleti...erand,producerofprescriptionsdrugsandlicensednatio...ublicChina,todayreporteditwillexhibitatthe,62ndPHA...on. ,, Time:November26-28,2009 , Venue:I...ijingdelegationfeaturesmorethantwentypharmaceutica...
Breaking Medicine Technology:Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Autism May Be Linked to Moms Autoimmune Disease 50779 1Autism May Be Linked to Moms Autoimmune Disease 50779 2Autism May Be Linked to Moms Autoimmune Disease 50779 3Autism May Be Linked to Moms Autoimmune Disease 50779 4Delirium in hospitalized adults 3A Situation critical no relief available 50777 1Delirium in hospitalized adults 3A Situation critical no relief available 50777 2Elderly breast cancer patients receive chemotherapy if treated in private practices 50775 1Elderly breast cancer patients receive chemotherapy if treated in private practices 50775 2Elderly breast cancer patients receive chemotherapy if treated in private practices 50775 3
... WIRE)--Mar 14, 2007 - ArQule, Inc.,(NASDAQ: ARQL)...ical Oncology (ASCO) has accepted for oral present...1 Dose Escalation Study of,ARQ 197, a Selective In...astatic Solid Tumors) at the 43rd ASCO Annual Meet... will describe findings,from a Phase 1 trial with ...
...s Presentation Of Phase II Trial Results,For Novel...ual,Meeting Of The American College Of Cardiology/...swire-FirstCall/ --,Schering-Plough Corporation an...f its novel oral thrombin receptor antagonist (TRA...Scientific Sessions,of the of Cardiology (ACC.07)/...
Other Medicine Technology:ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 2ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 3ArQule Announces Acceptance of Clinical Data on ARQ 197, c-Met,Inhibitor, for Oral Presentation at ASCO 4Media Advisory: ACC Updated Schedule 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: